Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Avantor (AVTR - Free Report) is a renowned global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The Zacks Consensus Estimate for its current year earnings has been revised 17.1% downward over the last 60 days.
BioTechne Corp (TECH - Free Report) is a global life sciences company which develops, manufactures, and sells biotechnology products and clinical diagnostic controls. The Zacks Consensus Estimate for its current year earnings has been revised 12.2% downward over the last 60 days.
Capri Holdings (CPRI - Free Report) provides women’s and men’s accessories, footwear and ready-to-wear, as well as wearable technology, watches, jewelry, eyewear and a full line of fragrance products. The Zacks Consensus Estimate for its current year earnings has been revised almost 5.6% downward over the last 60 days.
View the entire Zacks Rank #5 List.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Avantor (AVTR - Free Report) is a renowned global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The Zacks Consensus Estimate for its current year earnings has been revised 17.1% downward over the last 60 days.
BioTechne Corp (TECH - Free Report) is a global life sciences company which develops, manufactures, and sells biotechnology products and clinical diagnostic controls. The Zacks Consensus Estimate for its current year earnings has been revised 12.2% downward over the last 60 days.
Capri Holdings (CPRI - Free Report) provides women’s and men’s accessories, footwear and ready-to-wear, as well as wearable technology, watches, jewelry, eyewear and a full line of fragrance products. The Zacks Consensus Estimate for its current year earnings has been revised almost 5.6% downward over the last 60 days.
View the entire Zacks Rank #5 List.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Get the latest research report on TECH - FREE
Get the latest research report on CPRI - FREE
Get the latest research report on AVTR - FREE